Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Registry for End Stage Renal Failure (REIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02895425
Recruitment Status : Recruiting
First Posted : September 9, 2016
Last Update Posted : September 9, 2016
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier de Cayenne

Brief Summary:
The rein registry collects case record data from patients with end stage renal disease followed in French Guiana. This allows to generate incidence and rates for terminal renal disease, mortality rates for each territory. The regional data are pooled in order to get national statistics for end stage renal disease and transplantation activity in order to adapt prevention to the main causes of renal failure and treatment and care infrastructure.

Condition or disease Intervention/treatment
End Stage Renal Failure Other: Registry (No intervention)

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 1000 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 10 Years
Official Title: Réseau, Epidémiologie, Information, Néphrologie (Network Epidemiology Information Nephrology)
Study Start Date : January 2011
Actual Primary Completion Date : January 2011
Estimated Study Completion Date : January 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Kidney Failure




Primary Outcome Measures :
  1. Death [ Time Frame: 10 years ]
  2. Transplant [ Time Frame: 10 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient with End Stage Renal Failure followed in one of the dialisys sites in frnech Guiana
Criteria

Inclusion Criteria:

  • End Stage Renal Failure

Exclusion Criteria:

  • Refusal to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02895425


Locations
Layout table for location information
France
General Hospital of Cayenne Recruiting
Cayenne, French Guiana, France, 97306
Contact: Mathieu Nacher, MD, PhD    0594395024 ext 5024    mathieu.nacher@ch-cayenne.fr   
Sponsors and Collaborators
Centre Hospitalier de Cayenne

Additional Information:

Layout table for additonal information
Responsible Party: Centre Hospitalier de Cayenne
ClinicalTrials.gov Identifier: NCT02895425     History of Changes
Other Study ID Numbers: REIN
First Posted: September 9, 2016    Key Record Dates
Last Update Posted: September 9, 2016
Last Verified: September 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Centre Hospitalier de Cayenne:
Renal Transplant
Additional relevant MeSH terms:
Layout table for MeSH terms
Renal Insufficiency
Kidney Failure, Chronic
Kidney Diseases
Urologic Diseases
Renal Insufficiency, Chronic